Pharmacia & Upjohn switch-oriented OTC business has annual sales of about $400 mil..
This article was originally published in The Tan Sheet
Executive Summary
PHARMACIA & UPJOHN's SWITCH-ORIENTED OTC BUSINESSES will have combined annual sales of about $400 mil. worldwide. OTC sales are expected to comprise about 6% of a new entity, Pharmacia & Upjohn, that will be formed under a combination agreement announced by the two companies on Aug. 20. Pharmacia and Upjohn had approximately $6.8 bil. in combined revenues in 1994. Prescription pharmaceuticals represent about 78% of the merged entity's total sales based on 1994 figures.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning